| DB00002 | Cetuximab | approved | unknown | binder | Details |
| DB00110 | Palivizumab | approved, investigational | unknown | | Details |
| DB00111 | Daclizumab | investigational, withdrawn | unknown | | Details |
| DB09130 | Copper | approved, investigational | unknown | | Details |
| DB01593 | Zinc | approved, investigational | unknown | | Details |
| DB14487 | Zinc acetate | approved, investigational | unknown | | Details |
| DB14533 | Zinc chloride | approved, investigational | unknown | modulator | Details |
| DB14548 | Zinc sulfate, unspecified form | approved, experimental | unknown | modulator | Details |
| DB00112 | Bevacizumab | approved, investigational | unknown | | Details |